Company news

Gain Therapeutics, Inc. news in 2021

Gain Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Gain Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 27, 2021

Gain Therapeutics, Inc. Reports Third Quarter 2021 Financial Results and Business Update

November 11, 2021

Gain Therapeutics, Inc. Announces Breakthrough Pre-Clinical Data of Novel Small Molecules for the Treatment of Parkinson’s Disease and Gaucher Disease

November 9, 2021

Gain Therapeutics, Inc. Announces Appointment of Five Members to its Newly Formed Scientific Advisory Board (SAB)

October 25, 2021

Gain Therapeutics Appoints Matthias Alder as Chief Operating Officer

October 18, 2021

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease

September 7, 2021

Gain Therapeutics, Inc. Reports Second Quarter 2021 Financial Results and Business Update

August 10, 2021

Gain Therapeutics Announces Issuance of Two New PCT Patents Covering GBA and GALC Modulator Compounds for Treatment of CNS Disorders

June 9, 2021

Gain Therapeutics, Inc. Reports First Quarter 2021 Financial Results

May 9, 2021

Gain Therapeutics Presents Positive In Vitro & In Vivo Data on Its Orally Bioavailable Brain Penetrant Star Compounds for the Treatment of GBA1 Parkinson’s Disease & Related α-synucleopathies at the XXVI IAPRD World Congress

May 2, 2021

Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals

April 19, 2021

Gain Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option to Purchase Additional Shares

March 24, 2021

Gain Therapeutics Announces Pricing of Initial Public Offering of Common Stock

March 17, 2021

Decks in 2021